Tuesday, November 05, 2019 7:12:22 PM
I don't know if the earnings miss was calculated into the price already, but we have fallen for a long time. I agree with Carl, it is risky to sell and hope to re-buy lower. But doesn't that act in itself drive the madness?
Joe stated there were a lot of new players, and new products on the shelves; sales in the stores slumped overall, due to customer overload? I would expect that this issue would effect most companies. Several other players are reporting earnings shortly, it will be interesting to see their results.
It was heartening to hear that with CVSI talks with the FDA, that there are a few vendors who will thrive post FDA guidelines.
I didn't catch everything he stated on FDM and/or adding product to food. Did he state something about companies/products might be required to have GRAS/ self-GRAS?
Thanks
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM